Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 20

Showing 20 citing articles:

Expert consensus on the systemic treatment of atopic dermatitis in special populations
David N. Adam, Melinda Gooderham, Jennifer Beecker, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 6, pp. 1135-1148
Open Access | Times Cited: 49
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Karolina Makowska, Joanna Nowaczyk, Leszek Blicharz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 781-781
Open Access | Times Cited: 35
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis
Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 11, pp. 1240-1240
Closed Access | Times Cited: 23
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab
Hyung Don Kook, Ho Eun Gwag, So Yun Park, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 10, pp. 1939-1946
Closed Access | Times Cited: 6
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review
Lauren Schaefer, Nneka I. Comfere, Olayemi Sokumbi
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 2, pp. 153-164
Closed Access | Times Cited: 11
Cutaneous T-cell lymphoma in a JAK inhibitor patient: A case report
Sophy Mo, Dominique Friedmann
SAGE Open Medical Case Reports (2024) Vol. 12
Open Access | Times Cited: 2
Severely pruritic mycosis fungoides successfully treated with upadacitinib
Hyungdon Kook, So Yun Park, Narang Hong, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 3, pp. 450-451
Closed Access | Times Cited: 2
Pharmacological Trends in the Management of Atopic Dermatitis: A Comprehensive Review
Drishti M Bhatt, Adarshlata Singh, Bhushan Madke, et al.
Cureus (2024)
Open Access | Times Cited: 2
A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis
Jun-Hong Tsai, Tsen-Fang Tsai
Dermatitis (2023) Vol. 35, Iss. 1, pp. 24-42
Closed Access | Times Cited: 5
How to Understand Personalized Medicine in Atopic Dermatitis Nowadays?
Alicja Mesjasz, Karol Kołkowski, Andreas Wollenberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7557-7557
Open Access | Times Cited: 4
Rapid progression of cutaneous T-cell lymphoma in a patient with erythroderma during dupilumab treatment, following prior sequential azathioprine, baricitinib and cyclosporine treatments
Chang‐Yu Hsieh, Tsen‐Fang Tsai
Indian Journal of Dermatology Venereology and Leprology (2023) Vol. 90, pp. 353-355
Open Access | Times Cited: 3
Dupilumab, Atopic Dermatitis, and Mycosis Fungoides—New Insights on an Evolving Story
Joan Guitart
JAMA Dermatology (2023) Vol. 159, Iss. 11, pp. 1177-1177
Closed Access | Times Cited: 3
A case of Sézary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthritis
Kandai Saito, Takatoshi Shimauchi, Reiko Kageyama, et al.
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 391-393
Open Access | Times Cited: 4
Therapy and mechanism of natural polysaccharides for atopic dermatitis treatment
Wenjie Wang, Lijun Shao, Xiao Jiang, et al.
Deleted Journal (2024)
Open Access
Post-marketing safety of tralokinumab: a real-world pharmacovigilance study based on the FDA adverse event reporting system
Zeping Yang, Kejing Tang, Jie Chen
Expert Opinion on Drug Safety (2024)
Closed Access
Stark juckende Mycosis fungoides erfolgreich mit Upadacitinib behandelt
Hyungdon Kook, So Yun Park, Narang Hong, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 3, pp. 450-452
Closed Access
Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
Dongyang Zhao, Ling-Mei Huang, Jie Xiao, et al.
Medicine (2023) Vol. 102, Iss. 31, pp. e34516-e34516
Open Access | Times Cited: 1
Atopic dermatitis and cancer risk—New insights from mendelian randomization?
Laura Atzori
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 12, pp. 2397-2398
Open Access | Times Cited: 1
Development of cutaneous T‐cell lymphoma following exposure to biologic therapy: a Mayo Clinic retrospective analysis
Lauren Schaefer, Nneka I. Comfere, Olayemi Sokumbi
International Journal of Dermatology (2022) Vol. 62, Iss. 7
Closed Access | Times Cited: 1
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective
Alba Guglielmo, Maria Ludovica Deotto, Luigi Naldi, et al.
Dermatology Reports (2023)
Open Access
Page 1

Scroll to top